DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Carruthers MN, Topazian MD, Khosroshahi A. , et al.
Rituximab for IgG4-related disease: a prospective, open-label trial.
Ann Rheum Dis 2015;
74 (06) 1171-1177
We do not assume any responsibility for the contents of the web pages of other providers.